MI

MEDAREX, INC.

14 Marks
Corp.
First Filed:Apr 4, 1991Latest Filed:May 24, 2005Address:707 State Road, Princeton, NJ 08540

Portfolio Overview

Dead
14(100%)

Top Classes

Class 42
Software, IT Services & Scientific Research
7(50%)
Class 5
Pharmaceuticals
4(29%)
Class 31
Natural Agricultural Products
3(21%)

TTAB Proceedings

Total Proceedings
1
As Plaintiff
1(100%)
As Defendant
0(0%)

Top Firms

BRISTOL-MYERS SQUIBB COMPANY(May 2005)
7
SATTERLEE STEPHENS BURKE & B...(Mar 2001)
4

Trademark Portfolio

14 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
MEDAREX
MEDAREX
Service Mark
Word
CANCELLED
Owner:
Serial:78636321
Filed:May 24, 2005
Classes:42
Registration:3200575
Registered:Jan 23, 2007
MEDAREX
MEDAREX
Trademark
Word
CANCELLED
Owner:
Serial:78636312
Filed:May 24, 2005
Classes:5
Registration:3349554
Registered:Dec 4, 2007
KM-MOUSE
KM-MOUSE
Trademark
Word
CANCELLED
Owner:
Serial:76429201
Filed:Jul 11, 2002
Classes:31
Registration:2709232
Registered:Apr 22, 2003
Goods & Services
Transgenic living animals for laboratory use
ULTIMAB
ULTIMAB
Trademark
Word
ABANDONED
Owner:
Serial:78053006
Filed:Mar 14, 2001
Classes:31
Goods & Services
Class 031: transgenic living animals for laboratory use
ULTIMAB HUMAN ANTIBODY DEVELOPMENT SYSTEM
Owner:
Serial:78053007
Filed:Mar 14, 2001
Classes:42
Registration:2778623
Registered:Oct 28, 2003
Goods & Services
Class 042: Medical research, namely, the research, development and production of human antibodies
T12 DEVELOPMENT
T12 DEVELOPMENT
Service Mark
Stylized
ABANDONED
Owner:
Serial:76117553
Filed:Aug 28, 2000
Classes:42
Goods & Services
"DEVELOPMENT"
T-12 DEVELOPMENT
T-12 DEVELOPMENT
Service Mark
Word
ABANDONED
Owner:
Serial:76088499
Filed:Jul 13, 2000
Classes:42
Goods & Services
"DEVELOPMENT"
TRANS-PHAGE TECHNOLOGY
TRANS-PHAGE TECHNOLOGY
Service Mark
Word
CANCELLED
Owner:
Serial:76088615
Filed:Jul 13, 2000
Classes:42
Registration:2623104
Registered:Sep 24, 2002
Goods & Services
"TECHNOLOGY"
GENPHARM
GENPHARM
Service Mark
Word
CANCELLED
Owner:
Serial:76032727
Filed:Apr 24, 2000
Classes:42
Registration:2563026
Registered:Apr 23, 2002
HUMAB-MOUSE
HUMAB-MOUSE
Trademark
Word
CANCELLED
Owner:
Serial:74490454
Filed:Feb 15, 1994
Classes:31
Registration:2234442
Registered:Mar 23, 1999
Goods & Services
transgenic living animals for laboratory use
PUTTING THE IMMUNE SYSTEM TO WORK
CANCELLED
Owner:
Serial:74465001
Filed:Dec 3, 1993
Classes:42
Registration:1919025
Registered:Sep 12, 1995
Goods & Services
medical and pharmaceutical research services
MEDAREX
MEDAREX
Trademark
Word
CANCELLED
Owner:
Serial:74169009
Filed:May 22, 1991
Classes:1, 5
Registration:1944385
Registered:Dec 26, 1995
Goods & Services
monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome ("AIDS"), and other infectious diseases, autoimmune diseases, and cardiovascular diseases; biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding acquired cancer, immune deficiency syndrome ("AIDS"), and other infectious diseases, autoimmune diseases, and cardiovascular diseases
TRIGGER
TRIGGER
Trademark
Word
ABANDONED
Owner:
Serial:74161491
Filed:Apr 29, 1991
Classes:1, 5
Goods & Services
therapeutic pharmaceuticals preparations for use in the treatment of aids, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases and allergies,; biochemicals; namely, antibodies for in vitro or scientific research regarding aids, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases, and allergies; "TRIGGER"
BISPECIFIC
BISPECIFIC
Trademark
Word
ABANDONED
Owner:
Serial:74154100
Filed:Apr 4, 1991
Classes:1, 5
Goods & Services
therapeutic pharmaceutical preparations for use in the treatment of AIDS, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases and allergies; biochemicals; namely, antibodies for in vitro or scientific research regarding AIDS, infectious diseases, cancer, autoimmune diseases, cardiovascular diseases, and allergies

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.